American Well Corp
For the period ended Dec 31, 2023. Filed Feb 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 15, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNA TURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| American Well Corporation | ||
| Date: February 15, 2024 | By: | /s/ Ido Schoenberg, MD |
|---|---|---|
| Ido Schoenberg | ||
| Co-Chief Executive Officer | ||
| Date: February 15, 2024 | By: | /s/ Roy Schoenberg, MD, MPH |
| Roy Schoenberg | ||
| Co-Chief Executive Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Ido Schoenberg, MD | Co-Chief Executive Officer (principal executive officer) | February 15, 2024 |
| Ido Schoenberg | ||
| /s/ Roy Schoenberg, MD, MPH | Co-Chief Executive Officer (principal executive officer) | February 15, 2024 |
| Roy Schoenberg | ||
| /s/ Robert Shepardson | Chief Financial Officer(principal financial officer) | February 15, 2024 |
| Robert Shepardson | ||
| /s/ Paul McNeice | Chief Accounting Officer(principal accounting officer) | February 15, 2024 |
| Paul McNeice | ||
| /s/ Deval Patrick | Director | February 15, 2024 |
| Deval Patrick | ||
| /s/ Stephen Schlegel | Director | February 15, 2024 |
| Stephen Schlegel | ||
| /s/ Dr. Peter Slavin | Director | February 15, 2024 |
| Dr. Peter Slavin | ||
| /s/ Derek Ross | Director | February 15, 2024 |
| Derek Ross | ||
| /s/ Dr. Toby Cosgrove | Director | February 15, 2024 |
| Toby Cosgrove | ||
| /s/ Rob Webb | Director | February 15, 2024 |
| Rob Webb | ||
| /s/ Deborah Jackson | Director | February 15, 2024 |
| Deborah Jackson | ||
Index to consolidated Financial Statements
| Page(s) | |
| Report of Independent Registered Public Accounting Firm | F-2 |
|---|---|
| Consolidated Balance Sheets | F-4 |
| Consolidated Statements of Operations and Comprehensive Loss | F-5 |
| Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) | F-6 |
| Consolidated Statements of Cash Flows | F-7 |
| Notes to Consolidated Financial Statements | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.